Quantcast

Latest Cancer treatments Stories

Better Cancer Treatments May Follow Research In Outer Space
2014-02-28 10:25:13

Rebekah Eliason for redOrbit.com – Your Universe Online Although a necessary evil for a vast amount of people, systemic cancer treatment is an invasive procedure with devastating side effects. People undergoing cancer treatment often experience nausea, immune suppression, hair loss and organ failure. All of this is endured with the hope of exterminating the cancerous tissues in the body. If a treatment were developed to specifically target the cancerous tissue instead of treating the...

2014-02-27 23:27:37

A Belgian research team says new and experimental treatment approaches are poised to extend mesothelioma survival in the future. Raleigh, NC (PRWEB) February 27, 2014 Cancer researchers at Belgium’s Antwerp University Hospital say emerging mesothelioma treatments like hyperthermic intrapleural chemotherapy, immunotherapy, and photodynamic therapy are likely to transform multi-modal treatment of the cancer. As Surviving Mesothelioma reports, the team’s newly- published article in the...

2014-02-27 08:30:00

Patient Recruitment Now Underway at Treatment Centers Across the United States WOODCLIFF LAKE, N.J., Feb. 27, 2014 /PRNewswire/ -- Eisai Inc. today announced the start of a large, randomized Phase 3 trial to compare the efficacy, safety and tolerability of eribulin mesylate to standard weekly paclitaxel as a first- or second- line treatment for HER2-negative locally recurrent or metastatic breast cancer (MBC). Recruitment is currently active for this multicenter study, conducted in...

2014-02-25 12:27:52

Hyperthermia has shown to greatly improve cancer treatment outcomes when combined with radiation and chemotherapy, but Beverly Hills Thermal Medicine is one of only a few centers to offer it. BEVERLY HILLS, Calif., Feb. 25, 2014 /PRNewswire/ -- /Beverly Hills Thermal Medicine/- Hyperthermia treatments have shown to double response rates of chemotherapy and radiation without side effects, and are an integral part of cancer treatment in Europe, but despite this, it has not gained...

2014-02-20 12:28:45

PHILADELPHIA, Feb. 20, 2014 /PRNewswire/ -- MS -- According to a new report from the World Health Organization, cancer cases are expected to surge by 20 percent over the next two decades. The World Cancer Report, produced by the WHO's specialized cancer agency, predicts that new cancer cases will rise from 14 million annually in 2012 to 22 million within 20 years, leaving millions more to cope with the disease and the often debilitating and painful side effects of treatment plans that...

2014-02-13 04:20:48

Pierre Fabre are thus reinforcing their oncology portfolio which already enjoys a combination of chemotherapies, monoclonal antibodies and immuno-conjugates assets at various development phases CASTRES, France and BANGALORE, India, February 13, 2014 /PRNewswire/ -- Pierre Fabre, the third largest French pharmaceutical company, and Aurigene, a leading biotech company based in India, today announced that the two companies have entered into a collaborative license, development and...

Children In The EU Denied Cancer Treatments Due To Regulations
2014-02-11 14:45:11

Lee Rannals for redOrbit.com - Your Universe Online European Union (EU) regulations are causing children with cancer to go without treatments, according to the Institute of Cancer Research (ICR). Leading cancer experts said that EU rules are causing some children with cancer to be denied potentially life-saving drugs because the guidelines only allow companies to trial some drugs only in adults. The experts believe that changes to these rules could allow children access to high...

2014-02-11 12:26:43

Recurrent lung cancer responds to Integrative Immunotherapy SCOTTSDALE, Ariz., Feb. 11, 2014 /PRNewswire/ -- Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope. To view the multimedia assets associated with this release, please visit...

2014-02-10 12:26:14

GOSSELIES, Belgium, February 10, 2014 /PRNewswire/ -- iTeos Therapeutics SA today announced the filing of the Company's first patent applications protecting proprietary inhibitors of the intracellular enzyme TDO2, which is expressed at high levels in specific cancers. iTeos Therapeutics has collaborated with Ludwig Cancer Research over the last year to identify small molecule inhibitors of the enzyme that display nanomolar potency, good selectivity, favorable pharmacokinetics...

2014-02-03 12:29:37

Co-inventors of ATM technology joining company as General Manager of the ATM Program, Scientific Advisory Panel member, respectively SYDNEY, Feb. 3, 2014 /PRNewswire/ -- Novogen Limited (ASX: NRT; NASDAQ: NVGN), an oncology drug development company, today announced the appointments of Justine Stehn, PhD and Professor Peter Gunning, PhD to roles within the Company. Dr. Stehn and Professor Gunning are the co-inventors of the anti-tropomyosin (ATM) drug technology platform that Novogen...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin